Russell Investments Group Ltd. acquired a new position in shares of Envision Healthcare Co. (NYSE:EVHC) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 39,301 shares of the company’s stock, valued at approximately $2,527,000. Russell Investments Group Ltd. owned approximately 0.07% of Envision Healthcare at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Macquarie Group Ltd. raised its stake in shares of Envision Healthcare by 13.6% in the second quarter. Macquarie Group Ltd. now owns 119,800 shares of the company’s stock worth $3,040,000 after buying an additional 14,356 shares in the last quarter. British Columbia Investment Management Corp raised its stake in shares of Envision Healthcare by 47.7% in the third quarter. British Columbia Investment Management Corp now owns 97,850 shares of the company’s stock worth $2,179,000 after buying an additional 31,594 shares in the last quarter. Havens Advisors LLC raised its stake in shares of Envision Healthcare by 358.0% in the third quarter. Havens Advisors LLC now owns 160,301 shares of the company’s stock worth $3,570,000 after buying an additional 125,301 shares in the last quarter. Stonebridge Capital Management Inc. raised its stake in shares of Envision Healthcare by 149.1% in the third quarter. Stonebridge Capital Management Inc. now owns 22,420 shares of the company’s stock worth $499,000 after buying an additional 13,420 shares in the last quarter. Finally, First New York Securities LLC NY purchased a new stake in shares of Envision Healthcare during the third quarter worth about $134,000. 35.96% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Envision Healthcare Co. (NYSE:EVHC) opened at 63.16 on Tuesday. The firm’s market cap is $7.34 billion. Envision Healthcare Co. has a 52-week low of $57.32 and a 52-week high of $83.27. The firm has a 50-day moving average of $68.22 and a 200-day moving average of $45.67.

Envision Healthcare (NYSE:EVHC) last released its quarterly earnings results on Tuesday, February 28th. The company reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.24 by $0.09. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.41 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The company’s quarterly revenue was up 97.4% compared to the same quarter last year. During the same period last year, the firm earned $1.07 EPS. Equities analysts anticipate that Envision Healthcare Co. will post $1.40 EPS for the current year.

Your IP Address:

A number of equities research analysts recently issued reports on EVHC shares. Zacks Investment Research lowered shares of Envision Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 25th. Jefferies Group LLC set a $32.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a report on Sunday, December 4th. Oppenheimer Holdings Inc. raised shares of Envision Healthcare from a “market perform” rating to an “outperform” rating and set a $87.00 price objective for the company in a report on Wednesday, December 7th. They noted that the move was a valuation call. Goldman Sachs Group Inc started coverage on shares of Envision Healthcare in a report on Friday, December 9th. They issued a “buy” rating for the company. Finally, Canaccord Genuity reissued a “buy” rating on shares of Envision Healthcare in a report on Friday, December 9th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Envision Healthcare currently has an average rating of “Buy” and an average price target of $55.80.

In other news, Director John Thomas Gawaluck purchased 1,500 shares of the business’s stock in a transaction dated Friday, March 10th. The stock was acquired at an average price of $66.65 per share, with a total value of $99,975.00. Following the purchase, the director now directly owns 6,080 shares of the company’s stock, valued at approximately $405,232. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.30% of the company’s stock.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Receive News & Stock Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related stocks with our FREE daily email newsletter.